Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by davgroon Apr 22, 2022 11:38am
86 Views
Post# 34623850

RE:Another 3k

RE:Another 3k
Duster340 wrote: filled @77 maybe get the rest before the close. adding on the dips. expecting some news before the end of the month, also a throwing out a bone to davgro to buy since he has a problem buying in just prior to a stock selling off you have to look no further than his pot stocks. i kind of feel sorry for the little bugger.

Thanks for the sage investment advice Dust Pan.  NOT !!  So who has a "problem buying in just prior to a stock selling off" ??  HaHa.  Glad I didn't take your advice and load up on 7000+ shares like you did at 0.76 and 0.77 for the sole purpose of penny flipping.  If you are adding on the dips as you say; now is the time to BUY, BUY, BUY

It will be difficult now for the market makers to get the share price back to your buy price especially when someone dumps the equivalent of the daily trading volume in one fell swoop.  We are also in another RED day with the TSX down over 1%.  Very good chance ATE now heads back into the 60s unless positive news is released soon.
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse